Asymmetric Synthesis of a Small Molecule Inhibitor of TNFα via Enantioenriched 4-Substituted Tetrahydroisoquinolines
Abstract An improved decagram-scale enabling asymmetric synthesis of a lead small molecule inhibitor of TNFα is described. An overall >15-fold improvement in yield compared to the original route was accomplished through the development of a new chromatography-free enantioselective sequence that delivered >20 g of the target compound. Highlights of the new route include an efficient Parham cyclization that rapidly afforded hectagram quantities of a key dihydroisoquinolone, an uncommon asymmetric synthesis of 4-hydroxy and 4-amino tetrahydroisoquinoline intermediates, and improved Cu-free access to the unique heterocycle-rich pentacyclic scaffold.
Authors
- Gregory A. Gfesser
- Stephen N. Greszler (ORCID: https://orcid.org/0000-0003-1993-2417)
- Robert J. Altenbach
- Eric A. Voight (ORCID: https://orcid.org/0000-0002-9542-5356)
Institutions
- AbbVie (United States) (US)
Publication Details
- Journal
- Organic Letters
- Published
- 2026-11-13
- DOI
- https://doi.org/10.1021/acs.orglett.6c04407
- Primary Topic
- Isoquinoline Alkaloid Synthesis
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- AbbVie